Listed by the USPTO as MCLEOD, AFRICA MHAIRIE
Tech Center 1600 • Art Units: 1600 1635
This examiner grants 53% of resolved cases
MCLEOD, AFRICA MHAIRIE is assigned to Tech Center 1600 and art unit 1600. The record includes 53 resolved cases, with an allowance rate of 52.8%. The median time to allowance is 1406 days, indicating a long prosecution path for matters that reach allowance. The limited case base makes the figures directional rather than conclusive.
The interview lift is 67.7%, the strongest positive association in this profile. Counsel may give substantial attention to interview preparation, using the discussion to explain technical distinctions and identify amendments that address the examiner's concerns. The leading companies are Minghong Zhong, The Children's Hospital of Philadelphia, and Massachusetts Institute of Technology. The leading firms are Charney IP Law LLC, CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC, and Dunlap Bennett & Ludwig PLLC.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17961925 | PREDICTION, BIOSYNTHESIS, AND INTEGRATION AS BIOSENSORS OF MOLECULES WITH UNIQUE LIGHT ABSORBANCE SIGNATURES AND THEIR SUBSEQUENT IN-FIELD REMOTE DETECTION USING MULTI OR HYPER-SPECTRAL CAMERAS | Final Rejection | Massachusetts Institute of Technology |
| 18712070 | METHODS AND COMPOSITIONS FOR MODULATING FIBRINOGEN | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 18253198 | Systems and Methods for Diagnostic Assessment and Treatment of Insulin Resistance and Hyperglycemia | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18685204 | Nucleotides Comprising CasPhi Modified for Nuclear Targeting | Non-Final OA | Vanderbilt University |
| 17577942 | RECOMBINASE COMPOSITIONS AND METHODS OF USE | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 17999297 | GENETIC PHYSICAL UNCLONABLE FUNCTIONS AND METHODS OF USE THEREOF | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17611547 | TEMPERATURE-SENSITIVE RNA- Guided Endonuclease | Non-Final OA | Novozymes A/S |
| 18001269 | TRUNCATED PROMOTOR FOR RECOMBINANT GENE EXPRESSION | Final Rejection | DSM Austria GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.8% of resolved applications examined by Africa Mhairie Mcleod were allowed (53 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +67.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Africa Mhairie Mcleod took 1,406 days on average from filing to allowance.
Africa Mhairie Mcleod examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
